Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Aug;68(2):405–412. doi: 10.1172/JCI110269

Relationship between Platelet Secretion and Prothrombin Cleavage in Native Whole Blood

Mary Ellen Rybak 1,2,3, Herbert K Lau 1,2,3, Barbara Tomkins 1,2,3, Robert D Rosenberg 1,2,3, Robert I Handin 1,2,3
PMCID: PMC370812  PMID: 7263860

Abstract

To determine the relationship between platelet secretion and prothrombin conversion in whole blood, the release of platelet factor 4 and the generation of a Xa-specific cleavage product of prothrombin, fragment 1 + 2, were measured during the coagulation of whole blood. There was a parallel increase in the concentration of the two proteins. Over the first 5 min of incubation, platelet factor 4 concentration increased 6 ng/ml per min, and after 6-7 min, the rate of release increased to 750 ng/ml per min. Over the initial 5-7 min of incubation, fragment 1 + 2 concentration increased 1.5 pmol/ml per min with a subsequent increase of 45 pmol/ml per min. Incubation with 10 μM prostaglandin E1 or 15 μM prostaglandin I2 inhibited secretion of platelet factor 4 and delayed the onset of the rapid phase of fragment 1 + 2 generation by 8 min, while stimulation of platelet secretion with 1 μg/ml collagen suspension enhanced production of fragment 1 + 2. The addition of either 10 μM epinephrine or 100 ng/ml collagen suspension to whole blood did not affect either platelet factor 4 release or fragment 1 + 2 generation, although the combination of 3 μM epinephrine and 100 ng/ml collagen suspension enhanced platelet release and prothrombin cleavage.

The relationship between platelet factor 4 release and prothrombin cleavage was also studied in Factor VIII-deficient blood. When 0.001 U/ml factor VIII activity was present, <80 ng/ml platelet factor 4 were released, and no fragment 1 + 2 was generated after 30 min of incubation. The addition of 0.008-0.08 U/ml Factor VIII activity progressively increased platelet factor 4 release and prothrombin cleavage. Platelet factor 4 release was normal at 0.08 U/ml Factor VIII activity, whereas prothrombin cleavage was still delayed. Very little thrombin, the amount generated by the cleavage of 3-5 nM fragment 1 + 2, was needed to induce release of platelet factor 4.

Full text

PDF
407

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bolton A. E., Ludlam C. A., Pepper D. S., Moore S., Cash J. D. A radioimmunoassay for platelet factor 4. Thromb Res. 1976 Jan;8(1):51–58. doi: 10.1016/0049-3848(76)90122-5. [DOI] [PubMed] [Google Scholar]
  2. Downing M. R., Butkowski R. J., Clark M. M., Mann K. G. Human prothrombin activation. J Biol Chem. 1975 Dec 10;250(23):8897–8906. [PubMed] [Google Scholar]
  3. Handin R. I., Cohen H. J. Purification and binding properties of human platelet factor four. J Biol Chem. 1976 Jul 25;251(14):4273–4282. [PubMed] [Google Scholar]
  4. Heptinstall S., Taylor P. M. The effects of citrate and extracellular calcium ions on the platelet release reaction induced by adenosine diphosphate and collagen. Thromb Haemost. 1979 Aug 31;42(2):778–793. [PubMed] [Google Scholar]
  5. Kane W. H., Lindhout M. J., Jackson C. M., Majerus P. W. Factor Va-dependent binding of factor Xa to human platelets. J Biol Chem. 1980 Feb 10;255(3):1170–1174. [PubMed] [Google Scholar]
  6. Kaplan K. L., Nossel H. L., Drillings M., Lesznik G. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation. Br J Haematol. 1978 May;39(1):129–146. doi: 10.1111/j.1365-2141.1978.tb07135.x. [DOI] [PubMed] [Google Scholar]
  7. Lau H. K., Rosenberg J. S., Beeler D. L., Rosenberg R. D. The isolation and characterization of a specific antibody population directed against the prothrombin activation fragments F2 and F1 + 2. J Biol Chem. 1979 Sep 25;254(18):8751–8761. [PubMed] [Google Scholar]
  8. Lau H. K., Rosenberg R. D. The isolation and characterization of a specific antibody population directed against the thrombin antithrombin complex. J Biol Chem. 1980 Jun 25;255(12):5885–5893. [PubMed] [Google Scholar]
  9. Miletich J. P., Jackson C. M., Majerus P. W. Interaction of coagulation factor Xa with human platelets. Proc Natl Acad Sci U S A. 1977 Sep;74(9):4033–4036. doi: 10.1073/pnas.74.9.4033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Miletich J. P., Jackson C. M., Majerus P. W. Properties of the factor Xa binding site on human platelets. J Biol Chem. 1978 Oct 10;253(19):6908–6916. [PubMed] [Google Scholar]
  11. Miletich J. P., Kane W. H., Hofmann S. L., Stanford N., Majerus P. W. Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder. Blood. 1979 Nov;54(5):1015–1022. [PubMed] [Google Scholar]
  12. Miletich J. P., Majerus D. W., Majerus P. W. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets. J Clin Invest. 1978 Oct;62(4):824–831. doi: 10.1172/JCI109194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mustard J. F., Perry D. W., Kinlough-Rathbone R. L., Packham M. A. Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol. 1975 Jun;228(6):1757–1765. doi: 10.1152/ajplegacy.1975.228.6.1757. [DOI] [PubMed] [Google Scholar]
  14. PROCTOR R. R., RAPAPORT S. I. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol. 1961 Sep;36:212–219. doi: 10.1093/ajcp/36.3.212. [DOI] [PubMed] [Google Scholar]
  15. Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974 Oct;20(10):1255–1270. [PubMed] [Google Scholar]
  16. Rosenberg J. S., Beeler D. L., Rosenberg R. D. Activation of human prothrombin by highly purified human factors V and X-a in presence of human antithrombin. J Biol Chem. 1975 Mar 10;250(5):1607–1617. [PubMed] [Google Scholar]
  17. Shuman M. A., Levine S. P. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting. J Clin Invest. 1980 Feb;65(2):307–313. doi: 10.1172/JCI109673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Shuman M. A., Levine S. P. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting. J Clin Invest. 1980 Feb;65(2):307–313. doi: 10.1172/JCI109673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Shuman M. A., Levine S. P. Thrombin generation and secretion of platelet Factor 4 during blood clotting. J Clin Invest. 1978 Apr;61(4):1102–1106. doi: 10.1172/JCI109010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shuman M. A., Majerus P. W. The measurement of thrombin in clotting blood by radioimmunoassay. J Clin Invest. 1976 Nov;58(5):1249–1258. doi: 10.1172/JCI108579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Suttie J. W., Jackson C. M. Prothrombin structure, activation, and biosynthesis. Physiol Rev. 1977 Jan;57(1):1–70. doi: 10.1152/physrev.1977.57.1.1. [DOI] [PubMed] [Google Scholar]
  22. Tollefsen D. M., Jackson C. M., Majerus P. W. Binding of the products of prothrombin activation to human platelets. J Clin Invest. 1975 Jul;56(1):241–245. doi: 10.1172/JCI108075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tracy P. B., Peterson J. M., Nesheim M. E., McDuffie F. C., Mann K. G. Interaction of coagulation factor V and factor Va with platelets. J Biol Chem. 1979 Oct 25;254(20):10354–10361. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES